These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17376300)

  • 1. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy.
    Cao SL; Zhang QZ; Jiang XG
    Acta Pharmacol Sin; 2007 Apr; 28(4):584-90. PubMed ID: 17376300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
    Salunke SR; Patil SB
    Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
    Galgatte UC; Kumbhar AB; Chaudhari PD
    Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.
    Cai Z; Song X; Sun F; Yang Z; Hou S; Liu Z
    AAPS PharmSciTech; 2011 Dec; 12(4):1102-9. PubMed ID: 21879392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate.
    Cao SL; Ren XW; Zhang QZ; Chen E; Xu F; Chen J; Liu LC; Jiang XG
    Int J Pharm; 2009 Jan; 365(1-2):109-15. PubMed ID: 18822361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ion-activated
    Lavania K; Garg A
    Recent Adv Drug Deliv Formul; 2024; 18(1):35-49. PubMed ID: 38058093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel in situ gel formulation of ranitidine for oral sustained delivery.
    Xu H; Shi M; Liu Y; Jiang J; Ma T
    Biomol Ther (Seoul); 2014 Feb; 22(2):161-5. PubMed ID: 24753823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
    Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
    Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of mucoadhesive sprayable gellan gum fluid gels.
    Mahdi MH; Conway BR; Smith AM
    Int J Pharm; 2015 Jul; 488(1-2):12-9. PubMed ID: 25863119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Mahajan HS; Gattani S
    Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation pharmacokinetics of intranasal scopolamine gel formulation.
    Wu L; Boyd JL; Daniels V; Wang Z; Chow DS; Putcha L
    J Clin Pharmacol; 2015 Feb; 55(2):195-203. PubMed ID: 25187210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gellan gum fluid gels for topical administration of diclofenac.
    Mahdi MH; Conway BR; Mills T; Smith AM
    Int J Pharm; 2016 Dec; 515(1-2):535-542. PubMed ID: 27789369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration.
    Wei Y; Ying M; Xu S; Wang F; Zou A; Cao S; Jiang X; Wang Y
    Drug Deliv; 2016; 23(1):263-8. PubMed ID: 24865285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration].
    Tao T; Zhao Y; Yue P; Dong WX; Chen QH
    Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimotion sickness and antiemetic drugs.
    Wood CD
    Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277
    [No Abstract]   [Full Text] [Related]  

  • 18. Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition.
    Nižić L; Ugrina I; Špoljarić D; Saršon V; Kučuk MS; Pepić I; Hafner A
    Int J Pharm; 2019 May; 563():445-456. PubMed ID: 30965121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity.
    Hu KL; Mei N; Feng L; Jiang XG
    Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
    Offenloch K; Zahner G; Dietlein G; Franz I
    Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.